Egadro MF 80mg/250mg Tablet
Marketer
Arkle Healthcare Pvt Ltd
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Egadro MF 80mg/250mg Tablet
Combiflam MF 80mg/250mg tablets offer relief from abdominal pain. This dual-action formulation eases bloating, cramps, and discomfort by relaxing stomach and intestinal muscles and inhibiting pain-inducing neurotransmitters. Dosage and treatment duration for Combiflam MF 80mg/250mg tablets should strictly follow your physician's instructions, tailored to your individual response. Premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your doctor of all other medications you're using, as interactions are possible. Common side effects include nausea, vomiting, diarrhea, stomach upset, dry mouth, appetite loss, thirst, and heartburn; most are transient. Report any concerning side effects immediately. Drowsiness and dizziness may occur; avoid driving or activities requiring alertness until effects are known. Alcohol should be avoided due to potential dizziness intensification. Disclose any pregnancy, pregnancy plans, breastfeeding, kidney, or liver conditions before starting treatment to allow for appropriate dosage adjustment.
Primary Ingredients of Egadro MF 80mg/250mg Tablet
The provided text is "undefined," which lacks meaning and cannot be rephrased. A replacement is needed to fulfill the request.
Uses of Egadro MF 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Egadro MF 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. The Egadro MF 80mg/250mg Tablet should be administered with a meal.
Common Side effects of Egadro MF 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Egadro MF 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Consume Egadro MF 80mg/250mg tablets with food.
How Egadro MF 80mg/250mg Tablet works:
Each Egadro MF 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal discomfort and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle spasms, reducing contractions. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory substances responsible for pain and swelling in the abdomen.
SAFETY ADVICE
AlcoholUNSAFE
Combining Egadro MF 80mg/250mg Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Egadro MF 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any possible risks prior to prescription. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Egadro MF 80mg/250mg Tablet while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Egadro MF 80mg/250mg Tablets, a potential side effect of this medication, including dizziness.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Egadro MF 80mg/250mg tablets, as dosage modification may be necessary. A physician's consultation is advised. The use of Egadro MF 80mg/250mg tablets is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Egadro MF 80mg/250mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Egadro MF 80mg/250mg Tablet :
Should you forget to take your Egadro MF 80mg/250mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Egadro MF 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently